Germany: Who the Antibiotic Calls
Klebsiella pneumoniae is able to live asymptomatically in the intestine. But, once in the lungs, urinary tract or blood, it can cause pneumonia and other severe infections, up to sepsis - a life-threatening reaction of the body to infection. At risk are intensive care patients, newborns, the elderly and people with weakened immunity. A positive test does not mean a disease. And not all Klebsiella strains are resistant to antibiotics. German news in Russian

In a good detective, a criminal makes a mistake sooner or later. Leaves prints, gets confused in the testimony or falls for the trick of the investigator. In European hospitals, the story unfolds much more unpleasant. The suspect is known, his habits are studied, the means of neutralization are developed. But some varieties of this microscopic intruder manage to get away with it even after using the strongest drugs. And most alarmingly, the number of such stories is growing.
Medicine transplants organs, saves premature babies, conducts complex operations. But in front of microbes, which even antibiotics of the last reserve, sometimes loses. This enemy did not come from another planet. He has long lived with a man, and sometimes inside him.
Double-bottom bacteria
The name of the suspect is Klebsiella pneumoniae. Klebsiella is able to live asymptomatically in the intestine. But, once in the lungs, urinary tract or blood, it can cause pneumonia and other severe infections, up to sepsis - a life-threatening reaction of the body to infection. At risk are intensive care patients, newborns, the elderly and people with weakened immunity. A positive test does not mean a disease. And not all Klebsiella strains are resistant to antibiotics. Of particular concern are the varieties against which carbapenems do not work - powerful drugs used in severe infections, when other means do not help.
Plus a bad sign
On November 18, the European Center for Disease Prevention and Control (ECDC) presented statistics that doctors are not up to the holiday. In the EU, for 2019-2025, the estimated incidence of bloodstream infections caused by carbapenem-resistant Klebsiella increased by 72%. And the plan by 2030 is to reduce this figure by 5% compared to 2019. Instead of moving toward the goal, it moves in the opposite direction. In 2025, the EU average was 3.75 cases per 100,000 inhabitants. In Cyprus – 21.29, in Romania – 18.66, in Greece – 16.28. However, countries detect and register infections differently, so direct comparisons require caution. And most importantly: not all cases of Klebsiella infection, namely blood infections caused by certain resistant strains, increased by 72%. In severe cases, delay with effective therapy can cost lives.
Microbial armor
How does the bacterium respond to medication? Some of its varieties produce enzymes that destroy antibiotics. One of them is NDM: it helps neutralize carbapenems. There are strains that combine resistance to multiple drugs with an increased ability to cause severe illness. This is not a surrender of medicine. But the treatment options are becoming less. In severe infection, therapy begins without delay, and laboratory tests help to clarify the choice of drug. With sepsis, the bill can go by the clock.
The German chain
To think that the problem exists only in the south and east of Europe would be a dangerous illusion. In January 2026, Deutsches Ärzteblatt spoke about a study by the Robert Koch Institute and the Ruhr University of Bochum. The researchers examined cases of carriers and infections associated with Klebsiella, which produces NDM-1, identified in Germany from January 2022 to February 2023.
Most of the samples studied were genetically related. This suggests possible chains of transmission within the country, not just independent importation of bacteria. Carriage itself does not equal disease, but for weakened patients increases the risk.
In February 2026, German experts presented new recommendations for the treatment of severe infections caused by resistant bacteria, and in the fall, an online tool with data on antibiotic resistance appeared. The sooner doctors recognize the pathogen, the more accurately they will be able to choose treatment.
Minus without victory
There's a paradox. In 2025, antibiotic consumption in the EU was 5% lower than in 2019. However, the target for 2030 is a 20% reduction. This is not a call to deny patients therapy. We are talking about unnecessary appointments, the right choice of medicine and maintaining the effectiveness of reserve drugs.
In comparison, the incidence of blood infections caused by resistant Staphylococcus aureus MRSA decreased by 19 percent over the same six years. However, in the last two years, the indicator has started to grow again. Even notable success is not a reason to relax. Prevention does not begin with a prescription: hand hygiene, disinfection, rapid tests, if necessary - isolation of patients, as well as trained staff are necessary.
No high-profile diagnoses
Scare Europe with a “new pandemic” is spectacular, but incorrect. This is not about a sudden virus, but about a multi-year crisis of bacterial resistance to drugs. European health authorities estimate that infections caused by resistant microorganisms claim more than 35,000 lives each year in the EU and European Economic Area. These are common losses from various pathogens, not only from Klebsiella. It's not just infectious compartments at stake. Without reliable antibiotics, the risk of surgery, transplantation, chemotherapy and intensive care increases. Medicine is capable of incredible things, but even after a brilliant operation, it needs to cope with the infection. The darkest scenario is not empty pharmacy shelves. And shelves filled with drugs, before which the bacterium no longer retreats.
This is what Germany says:
Germany - Dad, Mom, I'm a percentage family. 80% Happiness, 50% Reality: New arithmetic awaits parents, and the federal budget is a possible savings
Germany – And you, friends, however you sit down. Discontent with the government is growing, but the Germans are in no hurry to change party sympathies. Will early elections lead to a repeat of old problems?
Germany is the cake of discord. Why even record budget billions may not be enough and who will be presented with the final bill?
Germany is a cold heart. Hot passions. The usual winter classics have a fabulous alternative. In Andersen's new ballet, love is tested by the willingness to give others freedom - the unexpected meanings of a familiar story
Germany: Two Loves in One Heart There are no boundaries between Pushkin and Goethe. Why do they exist between people, and can they be overcome?
Germany - Berlin said "A." Who teaches B? From 2029, four-year-olds will be tested for knowledge of German. Billions are promised for reform, but will there be educators to help those who need support?
Germany – Operation Chlorine and other Outlook adventures Let there always be a connection! 15 injured, faulty dispenser and undelivered distress letters. Why even a modern security system needs a backup plan?
Germany is a coalition with shortages. The AfD is increasing the gap, and the CDU/CSU and SPD are losing support. Why would the ruling parties lack the votes for a majority in the new Bundestag?
Germany is Glucose without an alibi. Sugar is quiet, yes, dashing: prediabetes does not warn about its appearance. What numbers should alert and why weight loss is useful, but not always saves from diabetes?
Germany: 21 rounds for six lives. Berlin trail in mass murder case: why gun seller accused of aiding crime
Germany - I would go to the Germans. Let them teach me! Foreign students are increasingly choosing German universities. But will studying lead to work and long-term living?
Germany - Five hours before divorce. The love has passed, investments withered: Mercedes spoke about the closure of factories and suggests workers to reconsider the terms of the union



